Use of pemetrexed as first line treatment of advanced non-small cell lung cancer: The Czech Republic experience with the treatment of 237 patients (pts)
Lung Cancer(2012)
摘要
The Czech Republic has had an opportunity to use pemetrexed for 1st line treatment of advanced NSCLC from the year 2008. The purpose of this trial was to evaluate the activity and feasibility of pemetrexed in 1st line treatment NSCLC patients.
更多查看译文
关键词
pemetrexed,lung cancer,non-small
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要